Evidence map›Paper›PMID 26842651›Full record

ArticleCommunicative & integrative biology2014

A novel caveolin-1/p85α/Rab5/Tiam1/Rac1 signaling axis in tumor cell migration and invasion.

Jorge Díaz, Pablo Mendoza, Patricio Silva, Andrew Fg Quest, Vicente A Torres

Open access · goldAbstract read
In one paragraph

Article in Communicative & integrative biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Jorge DíazInstitute for Research in Dental Sciences; Faculty of Dentistry; Universidad de Chile; Santiago, Chile; Center for Molecular Studies of the Cell (CEMC); Advanced Center for Chronic Diseases (ACCDiS); Cell and Molecular Biology Program; Biomedical Sciences Institute (ICBM); Faculty of Medicine; Universidad de Chile; Santiago, Chile.
Pablo MendozaInstitute for Research in Dental Sciences; Faculty of Dentistry ; Universidad de Chile ; Santiago, Chile.
Patricio SilvaInstitute for Research in Dental Sciences; Faculty of Dentistry ; Universidad de Chile ; Santiago, Chile.
Andrew Fg QuestCenter for Molecular Studies of the Cell (CEMC); Advanced Center for Chronic Diseases (ACCDiS) ; Cell and Molecular Biology Program; Biomedical Sciences Institute (ICBM) ; Faculty of Medicine; Universidad de Chile ; Santiago, Chile.
Vicente A TorresInstitute for Research in Dental Sciences; Faculty of Dentistry ; Universidad de Chile ; Santiago, Chile.
University of Chile · CLFaculty (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The small GTPase Rab5 has been frequently studied in the context of intracellular trafficking, but evidence obtained more recently has implicated Rab5 as a critical regulator of cell adhesion, migration and invasion in both normal and tumor cells. These recent findings showing that Rab5 promotes Rac1 activation and focal adhesion dynamics have highlighted the question as to what the upstream regulators of Rab5 activity might be and how these are connected to cell migration. The efforts to shed light on this issue identified in metastatic cancer cells a novel Caveolin‑1/p85α/Rab5/Tiam1/Rac1 signaling axis relevant to cancer cell migration and invasion. In this addendum, we highlight aspects concerning Rab5 regulation in this context.

Indexed as

Caveolin-1cell migrationinvasionp85αRab5Rac1

Identifiers

PMID26842651
PMCPMC4594484
OpenAlexW1995255666

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.